The role of tumor necrosis factor in viral disease

Aderka, 1991, Increased serum levels of soluble receptors for Tumor Necrosis Factor in cancer patients, Cancer Res., 51, 5602 Aderka, 1992, Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors, J. Exp. Med., 175, 323, 10.1084/jem.175.2.323 Aderka, 1986, Tumor necrosis factor induction by Sendai virus, J. Immunol., 136, 2938, 10.4049/jimmunol.136.8.2938 Aderka, 1985, Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon, Cell Immunol., 91, 218, 10.1016/0008-8749(85)90003-6 Aggarwal, 1985, Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon, Nature, 318, 665, 10.1038/318665a0 Allen, 1976, Differential sensitivity of Rauscher murine leukemia virus (MuLV-R) to interferons in two interferon-responsive cell lines, J. Gen. Virol., 31, 429, 10.1099/0022-1317-31-3-429 Ammann, 1987, Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, J. Clin. Immunol., 7, 481, 10.1007/BF00915059 Arakawa, 1987, The antiviral activity of recombinant human tumor necrosis factor-α, J. Interferon Res., 7, 103, 10.1089/jir.1987.7.103 Aversa, 1993, The 26 kD transmembrane form of Tumor Necrosis Factor α on activated CD4+ T cell clones provides a costimulatory signal for tumor B cell activation, J. Exp. Med., 177, 1575, 10.1084/jem.177.6.1575 Baldwin, 1987, Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene, Mol. Cell. Biol., 7, 305, 10.1128/MCB.7.1.305 Baldwin, 1988, Two transcription factors, NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter, 85, 723 Balkwill, 1987, Evidence for tumour necrosis factor/cachectin production in cancer, Lancet, 2, 1229, 10.1016/S0140-6736(87)91850-2 Banerjee, 1992, Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-α, AIDS, 6, 1127, 10.1097/00002030-199210000-00010 Bate, 1988, Malarial parasites induce TNF production by macrophages, Immunology, 64, 227 Becker, 1991, Cytokine (Tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages, J. Immunol., 147, 4307, 10.4049/jimmunol.147.12.4307 Berent, 1986, Sendai virus induces high levels of tumor necrosis factor mRNA in human peripheral blood leukocytes, Nuc. Acids Res., 14, 8997, 10.1093/nar/14.22.8997 Bersani, 1987, Cytotoxic effector function of B lymphoblasts, J. Immunol., 139, 645, 10.4049/jimmunol.139.2.645 Beutler, 1986, Cachectin and tumour necrosis factor as two sides of the same biological coin, Nature, 320, 584, 10.1038/320584a0 Beutler, 1988, Tumor necrosis, cachexia, shock, and inflammation: A common mediator, Ann. Rev. Biochem., 57, 505, 10.1146/annurev.bi.57.070188.002445 Beutler, 1985, Identity of tumour necrosis factor and the macrophage-secreted factor cachectin, Nature, 316, 552, 10.1038/316552a0 Beutler, 1985, Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells, J. Exp. Med., 161, 984, 10.1084/jem.161.5.984 Bielefeldt Ohmann, 1988, Influence of interferons αI1 and γ and of tumour necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro, J. Gen. Virol., 69, 1399, 10.1099/0022-1317-69-6-1399 Billiau, 1988, “Interleukin-6: Structure, production and actions”, 3 Blanchard, 1988, Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function, J. Leuk. Biol., 43, 429, 10.1002/jlb.43.5.429 Blanchard, 1989, Induction of interferon-gamma and tumor necrosis factory by Legionella pneumophila: Augmentation of human neutrophil bactericidal activity, J. Leuk. Biol., 45, 538, 10.1002/jlb.45.6.538 Blick, 1987, Phase I study of recombinant tumor necrosis factor in cancer patients, Cancer Res., 47, 2986 Bohnlein, 1988, The same inducible nuclear proteins regulate mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV, Cell, 53, 827, 10.1016/0092-8674(88)90099-2 Boshart, 1985, A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus, Cell, 41, 521, 10.1016/S0092-8674(85)80025-8 Caput, 1986, Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators, 83, 1670 Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, 72, 3666 Chapes, 1979, Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization, J. Immunol., 123, 303, 10.4049/jimmunol.123.1.303 Cherrington, 1989, Human cytomegalovirus iel transactivates the alpha promoter-enhancer via an 18-base-pair repeat element, J. Virol., 63, 1435, 10.1128/JVI.63.3.1435-1440.1989 Chiu, 1987, Multiple cis- and transacting elements mediate the transcriptional response to phorbol esters, Nature. (London), 329, 648, 10.1038/329648a0 Clouse, 1989, Monokine regulation of human immunodeficiency virus-1 expression in a chronically-infected human T cell clone, J. Immunol., 142, 431, 10.4049/jimmunol.142.2.431 Cotran, 1989, Effects of cytokines on vascular endothelium: Their role in vascular and immune injury, Kidney International, 35, 969, 10.1038/ki.1989.80 Creasey, 1983, Growth regulation of melanoma cells by interferon and 2′–5′ oligo-adenylate synthetase, Mol. Cell Biol., 3, 780, 10.1128/MCB.3.5.780 Cuturi, 1987, Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes, J. Exp. Med., 65, 1581, 10.1084/jem.165.6.1581 Czarniecki, 1984, Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells, Antiviral Res., 4, 351, 10.1016/0166-3542(84)90006-8 Czarniecki, 1984, Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human α, β and γ infereons, J. Virol., 49, 490, 10.1128/JVI.49.2.490-496.1984 Czarniecki, 1981, Dissociation of interferon effects on murine leukemia virus and encephalomycarditis virus replication, J. Virol., 37, 827, 10.1128/JVI.37.2.827-831.1981 Davison, 1986, The complete DNA sequence of varicella-zoster virus, J. Gen. Virol., 67, 1759, 10.1099/0022-1317-67-9-1759 Domke-Opitz, 1986, Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages, J. Virol., 60, 37, 10.1128/JVI.60.1.37-42.1986 Duh, 1989, Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat, 86, 5974 Domke, 1985, Inhibition of replication of herpes simplex virus in mouse macrophages by interferons, J. Gen. Virol., 66, 2231, 10.1099/0022-1317-66-10-2231 Faltyneck, 1985, Different mechanisms for activation of gene transcription by interferons β and 7, Virol., 144, 173, 10.1016/0042-6822(85)90315-0 Feduchi, 1989, Human interferon gamma and tumor necrosis factor exert a synergistic blockade on the replication of herpes simlex virus, J. Virol., 63, 1354, 10.1128/JVI.63.3.1354-1359.1989 Feduchi, 1991, Mechanism of inhibition of HSV-1 replication by Tumor Necrosis Factor and Interferon-γ, Virology, 180, 822, 10.1016/0042-6822(91)90100-P Flamand, 1991, Human Herpesvirus 6 induces Interleukin-1b and Tumor Necrosis Factor Alpha, but not Interleukin-6, in peripheral blood mononuclear cell cultures, J. Virology, 65, 5105, 10.1128/JVI.65.9.5105-5110.1991 Fleishman, 1979, Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon, Infect. Immun., 26, 248, 10.1128/IAI.26.1.248-253.1979 Folks, 1989, Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically-infected T-cell clone, 86, 2365 Folks, 1987, Cytokine-induced expression of HIV-1 in a chronically-infected promonocyte cell line, Science, 238, 800, 10.1126/science.3313729 Folks, 1986, Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV, J. Immunol., 136, 4049, 10.4049/jimmunol.136.11.4049 Fransen, 1985, Molecular cloning of mouse tumor necrosis cDNA and its eukaryotic expression, Nuc. Acids Res., 13, 4417, 10.1093/nar/13.12.4417 Friedman, 1977, Antiviral activity of interferons, Bacteriol. Rev., 41, 543, 10.1128/MMBR.41.3.543-567.1977 Friedman-Einat, 1982, Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemic cells, Mol. Cell Biol., 2, 1472, 10.1128/MCB.2.12.1472 Fukuda, 1988, Simultaneous production of natural human tumor necrosis factor-α, -β and interferon-α from BALL-1 cells stimulated by HVJ, Lymphokine Res., 7, 175 Gessani, 1988, The antiviral activity of tumor necrosis factor in HeLa cells is not mediated by interferons, J. Biol. Regulators and Homoestatic Agents, 2, 139 Goldfield, 1989, Coordinate viral induction of tumor necrosis factor-α and interferon β in human B cells and monocytes, 1490 Godfried, 1993, AIDS, 7, 33, 10.1097/00002030-199301000-00005 Gosselin, 1992, Infection of peripheral blood mononuclear cells by Herpes simplex and Epstein-Barr viruses: Differential induction of Interleukin 6 and Tumor Necrosis Factor-α, J. Clin. Invest., 89, 1849, 10.1172/JCI115789 Greve, 1989, The major human rhinovirus receptor is ICAM-1, Cell, 56, 839, 10.1016/0092-8674(89)90688-0 Griffin, 1989, Activation of HIV gene expression during monocyte differentiation by induction of NF-κB, Nature, 339, 70, 10.1038/339070a0 Haas, 1987, Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders, Scand. J. Immunol., 26, 371, 10.1111/j.1365-3083.1987.tb02269.x Haranaka, 1984, Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice, Int. J. Cancer, 34, 263, 10.1002/ijc.2910340219 Heller, 1990, Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of receptor, 87, 6151 Henke, 1992, Coxsackievirus B3-induced production of Tumor Necrosis Factor-α, IL-1β, and IL-6 in human monocytes, J. Immunol., 148, 2270, 10.4049/jimmunol.148.7.2270 Howard, 1993, Soluble tumor necrosis factor receptor: Inhibition of human immunodeficiency virus activation, 90, 2335 Israel, 1987, A common positive trans-acting factor binds to enhancer sequences in the promotors of mouse H-2 and β2-microglobulin genes, 84, 2653 Ito, 1989, Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro, Biochem. Biophys. Res. Commun., 158, 307, 10.1016/S0006-291X(89)80213-X Ito, 1987, Antiviral effects of recombinant human tumor necrosis factor, Lymphokine Res., 6, 309 Jacobsen, 1989, Beta-Interferon subtype induction by tumor necrosis factor, Mol. Cell. Biol., 9, 3037, 10.1128/MCB.9.7.3037 Jones, 1992, Tumor Necrosis Factor-α in advanced HIV infection in the absence of AIDS-related secondary infections, J. Acq. Immun. Def. Syn., 5, 1266 Kettelhut, 1987, The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors, 84, 4273 Koff, 1986, Human tumor necrosis factor-α kills herpesvirus-infected but not normal cells, Lymphokine Res., 5, 215 Kohase, 1986, Induction of β2-Interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation, Cell, 45, 659, 10.1016/0092-8674(86)90780-4 Kohase, 1988, Interleukin-1 can inhibit interferon-β synthesis and its antiviral action: comparison with tumor necrosis factor, J. Interferon Res., 8, 559, 10.1089/jir.1988.8.559 Kornbluth, 1989, Interferons and bacterial lipopolysaccaride protect macrophages from productive infection by human immunodeficiency virus in vitro, J. Exp. Med., 169, 1137, 10.1084/jem.169.3.1137 Kriegler, 1988, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 53, 45, 10.1016/0092-8674(88)90486-2 Lahdevirta, 1988, Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome, Am. J. Med., 85, 289, 10.1016/0002-9343(88)90576-1 Le, 1987, Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities, Lab. Invest., 56, 234 Leeuwenberg, 1987, Interferon-β1 an intermediate in the tumor necrosis factor-α-induced increased MHC Class I expression and an autocrine regulator of the constitutive MHC Class I expression, J. Exp. Med., 166, 1180, 10.1084/jem.166.4.1180 Lenardo, 1989, NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control, Cell, 58, 227, 10.1016/0092-8674(89)90833-7 Lenardo, 1989, The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction, Cell, 57, 287, 10.1016/0092-8674(89)90966-5 Leung, 1988, HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor, Nature (London), 333, 776, 10.1038/333776a0 Lowenthal, 1989, Tumor necrosis factor α activition of the IL-2 receptor-α gene involves the induction of κB-specific DNA-binding proteins, J. Immunol., 142, 3121, 10.4049/jimmunol.142.9.3121 Lowenthal, 1989, Tumor necrosis factor α induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor α-chain gene expression in primary human T lymphocytes, 86, 2331 Mak, 1982, The generation of ‘cytotoxic’ macrophages in mice during infection with Influenza A or Sendai virus, Scand. J. Immunol., 15, 553, 10.1111/j.1365-3083.1982.tb00683.x Margolick, 1987, Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses, J. Immunol., 138, 1719, 10.4049/jimmunol.138.6.1719 Matsuyama, 1988, Enhancement of human immunodeficiency virus production by natural lymphotoxin, Med. Microbiol. Immunol., 177, 181, 10.1007/BF00211217 Matsuyama, 1988, Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, Molt-4/HIVHTLV-IIIB cells, Jpn. J. Cancer Res., 79, 156, 10.1111/j.1349-7006.1988.tb01571.x Matsuyama, 1989, Cytocidal effect of tumor necrosis factor on cells chronically-infected with human immunodeficiency virus (HIV): Enhancement of HIV replication, J. Virol., 63, 2504, 10.1128/JVI.63.6.2504-2509.1989 Matsuyama, 1989, Enhancement of HIV replication and giant cell formation by tumor necrosis factor, AIDS Research and Human Retroviruses, 5, 139, 10.1089/aid.1989.5.139 McDougal, 1985, Cellular tropism of the human retrovirus HTLV-III/LAV.I. Role of T cell activation and expression of the T4 antigen, J. Immunol., 135, 3151, 10.4049/jimmunol.135.5.3151 Mellors, 1991, Tumor necrosis factor-a/cachectin enhances human immunodeficiency virus Type 1 replication in primary human macrophages, J. Infec. Dis., 163, 78, 10.1093/infdis/163.1.78 Mestan, 1988, Antiviral activity of tumor necrosis factor, J. Gen. Virol., 69, 3113, 10.1099/0022-1317-69-12-3113 Mestan, 1986, Antiviral effects of reombinant tumor necrosis factor in vitro, Nature, 323, 816, 10.1038/323816a0 Michihiko, 1989, Augmentation of in vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor, Lancet, 1, 1206, 10.1016/S0140-6736(89)92788-8 Mintz, 1989, Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome, Am. J. Dis. Childr., 143, 771 Mitchell, 1987, Positive and negative regulation of transcription in vitro: enchancer-binding protein AP-2 is inhibited by SV40 T antigen, Cell, 50, 847, 10.1016/0092-8674(87)90512-5 Molina, 1990, Human Immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells, J. Virol., 64, 2901, 10.1128/JVI.64.6.2901-2906.1990 Molina, 1989, Production of tumor necrosis factor α and interleukin 1β by monocytic cells infected with human immunodeficiency virus, J. Clin. Invest., 84, 733, 10.1172/JCI114230 Movat, 1987, Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury, J. Lab. Clin. Med., 110, 668 Muesing, 1987, Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein, Cell, 48, 691, 10.1016/0092-8674(87)90247-9 Munis, 1990, Human immunodeficiency virus-1 infection of macrophages in vitro neither induces Tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction of lipopolysaccharide, J. Clin. Invest., 85, 591, 10.1172/JCI114478 Nabel, 1987, An inducible transcription factor activates expression of human immunodeficiency virus in T cells, Nature, 326, 711, 10.1038/326711a0 Nain, 1990, Tumor Necrosis Factor-α production of Influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides, J. Immunol., 145, 1921, 10.4049/jimmunol.145.6.1921 Nilsen, 1980, Virus-specific effects of interferon on embryonal carcinoma cells, Nature (London), 286, 178, 10.1038/286178a0 Oleszak, 1985, Potentiation of the antiviral and anticellular activities of interferons by mixtures of huIFN-γ and huIFN-α, or huIFN-β, J. Interferon Res., 5, 361, 10.1089/jir.1985.5.361 Osborn, 1989, Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB, 86, 2336 Pennica, 1985, Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor, 82, 6060 Pennica, 1984, Human tumor necrosis factor: precursor structure, cDNA cloning, expression and homology to lymphotoxin, Nature, 312, 724, 10.1038/312724a0 Peters, 1986, Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes, J. Immunol., 137, 2592, 10.4049/jimmunol.137.8.2592 Peterson, 1992, Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a Tumor Necrosis Factor-α-mediated mechanism, J. Clin. Invest., 89, 574, 10.1172/JCI115623 Pfeffer, 1993, Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection, Cell, 73, 457, 10.1016/0092-8674(93)90134-C Pober, 1987, Effects of tumor necrosis factor and related cytokines on vascular endothelial cells, 170 Ray, 1988, Activation of the human “β2-interferon/hepatocyte-stimulating factor/interleukin 6” promoter by cytokines, viruses, and second messenger agonists, 85, 6701 Reddy, 1988, Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations, Journal of Acquired Immune Deficiency Syndrome, 1, 436 Reis, 1988, Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-β2, and is inhibited by specific antibodies to IFN-β, J. Immunol., 140, 1566, 10.4049/jimmunol.140.5.1566 Roberts, 1984, Pathologic changes of experimental varicella (delta herpesvirus) infection in African green monkeys (Cercopithecus aethios), Am. J. Vet. Res., 45, 523 Rosenberg, 1989, Immunopathogenic mechanisms of HIV infection, Clin. Immunol. and Immunopath., 50, S149, 10.1016/0090-1229(89)90122-0 Rossel-Voth, 1991, In vivo protective effect of tumor necrosis factor α against experimental infection with herpes simplex virus type 1, J. Gen. Virol., 72, 143, 10.1099/0022-1317-72-1-143 Roux-Lombard, 1989, Purified blood monocytes from HIV 1-infected patients produce high levels of TNF-α and IL-1, Clin. Immunol. Immunopath., 50, 374, 10.1016/0090-1229(89)90144-X Ruben, 1988, Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product, Science, 241, 89, 10.1126/science.2838905 Ruggiero, 1989, The in vitro antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-β induction, Antiviral Res., 11, 77, 10.1016/0166-3542(89)90010-7 Ruggiero, 1989, Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells, Immunology Letters, 21, 165, 10.1016/0165-2478(89)90054-0 Samuel, 1987, Interferon induction of the antiviral state: proteins induced by interferons and their possible roles in the antiviral mechanisms of interferon action, 111 Samuel, 1981, Mechanism of interferon action: cloned human leukocyte interferons induce protein kinase and inhibit vesicular stomatitis virus but not reovirus replication on human amnion cells, Virology, 114, 302, 10.1016/0042-6822(81)90282-8 Scuderi, 1986, Raised serum levels of tumor necrosis factor in parasitic infections, Lancet, 2, 1364, 10.1016/S0140-6736(86)92007-6 Sen, 1986, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 46, 705, 10.1016/0092-8674(86)90346-6 Sen, 1986, Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism, Cell, 47, 921, 10.1016/0092-8674(86)90807-X Shalaby, 1985, In vivo antiviral activity of recombinant murine γ-interferon, J. Interferon Res., 5, 339, 10.1089/jir.1985.5.339 Shibuya, 1989, Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes, Int. Immunol., 1, 43, 10.1093/intimm/1.1.43 Smith, 1990, A receptor for tumor necrosis factor defines an unusual family of Cellular and viral proteins, Science, 248, 1019, 10.1126/science.2160731 Smith, 1992, Cytomegalovirus induction of Tumor Necrosis Factor-α by human monocytes and mucosal macrophages, J. Clin. Invest., 90, 1642, 10.1172/JCI116035 Soike, 1989, Enhancement of simian varicella virus infection in African green monkeys by recombinant human tumor necrosis factor α, J. Infect. Dis., 159, 331, 10.1093/infdis/159.2.331 Soike, 1987, Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and recombinant human β-interferon alone and in combination on simian varicella virus infection in monkeys, J. Infec. Dis., 156, 607, 10.1093/infdis/156.4.607 Soike, 1983, In vivo antiviral activity of recombinant type α-interferon A in monkeys with infections due to simian varicella virus, J. Infec. Dis., 147, 933, 10.1093/infdis/147.5.933 Spies, 1986, Genes for the tumor necrosis factors α and β are linked to the major histocompatability complex, 83, 8699 Sriram, 1991, In vivo administration of TNF-α prevents EMC-M virus induced viral encephalitis, Int. Immunol., 3, 641, 10.1093/intimm/3.7.641 Staunton, 1989, A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses, Cell, 56, 849, 10.1016/0092-8674(89)90689-2 Stanwick, 1982, Cytotoxic properties of human monocyte-macrophages for human fibroblasts infected with herpes simplex virus: interferon production and augmentation, Cell. Immunol., 70, 132, 10.1016/0008-8749(82)90139-3 Stewart, 1979 Stringfellow, 1974, interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyinosinic polycytidylic acid and tilorone hydrochloride on viral pathogenesis, J. Infec. Dis., 130, 470, 10.1093/infdis/130.5.470 Sung, 1988, Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells, J. Exp. Med., 168, 1539, 10.1084/jem.168.5.1539 Tilg, 1991, Cachexia and tumor necrosis factor-α in cytomegalovirus infection, J. Clin. Pathol., 44, 519, 10.1136/jcp.44.6.519 Tomita, 1982, Human interferon suppression of retrovirus production and cell fusion and failure to inhibit replication of encephalomyocarditis virus in rhabdomyosarcoma (RD114) cells, Virology, 120, 258, 10.1016/0042-6822(82)90025-3 van Damme, 1987, The role of IFN-β and the 26-kDa protein (interferon-β2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor, J. Immunol., 139, 1867, 10.4049/jimmunol.139.6.1867 Waage, 1987, Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease, Lancet, 1, 355, 10.1016/S0140-6736(87)91728-4 Wallach, 1984, Preparations of lymphotoxin induce resistance to their own cytotoxic effect, J. Immunol., 132, 2464, 10.4049/jimmunol.132.5.2464 Whitaker-Dowling, 1987, Antiviral effects of interferon in different virushost cell systems, 83 Wong, 1986, Tumor necrosis factor α and β inhibit virus repliction and synergize with interferons, Nature, 323, 819, 10.1038/323819a0 Wong, 1988, In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ, J. Immunol., 140, 120, 10.4049/jimmunol.140.1.120 Wright, 1988, Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients, J. Immunol., 141, 99, 10.4049/jimmunol.141.1.99 Yagi, 1987, Tumor necrosis factor enhances murine SL3-3 retrovirus replication, J. Clin. Lab. Immunol., 24, 129 Yarden, 1984, Autogenous production of interferon-β switches on HLA genes during differentiation of histiocytic lymphoma U937 cells, Embo J., 3, 969, 10.1002/j.1460-2075.1984.tb01915.x Zagury, 1986, Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS, Science, 231, 850, 10.1126/science.2418502